Your session is about to expire
← Back to Search
Vaginoscopy vs Traditional Hysteroscopy for Fibroids
N/A
Waitlist Available
Led By Carole KAMGA-NGANDE, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Polyp less than 2 cm
If more than 1 fibroid: total fibroid have to be less or equal 4 cm
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Study Summary
This trial is testing whether a new way to do a hysteroscopy (vaginoscopy) is less painful than the traditional method.
Who is the study for?
This trial is for women aged 18-52 who need a polypectomy or myomectomy due to abnormal bleeding or fertility issues. They must have small polyps or fibroids previously diagnosed by hysteroscopy. Women with large fibroids, cervical stenosis, blood disorders, or pregnancy cannot participate.Check my eligibility
What is being tested?
The study compares pain levels between two procedures: vaginoscopy and traditional hysteroscopy during outpatient treatment of uterine conditions like fibroids. The hypothesis is that vaginoscopy causes less pain than the standard method.See study design
What are the potential side effects?
While not explicitly stated in the provided information, potential side effects may include discomfort, cramping, bleeding similar to menstrual periods, and possible infection risks associated with hysteroscopic procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My polyp is smaller than 2 cm.
Select...
My fibroids are 4 cm or smaller in total if I have more than one.
Select...
I have a small fibroid inside the wall of my uterus.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hysteroscopy
Secondary outcome measures
Difference in length of time of procedure between vaginoscopy group and traditional hysteroscopy group
Hysteroscopy
Difference in length of time to pregnancy between vaginoscopy group and traditional hysteroscopy group
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VaginoscopyExperimental Treatment1 Intervention
morcellation hysteroscopy with only intravenous sedation
Group II: Standard hysteroscopyActive Control1 Intervention
morcellation hysteroscopy with intravenous sedation and paracervical bloc
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
vaginoscopy
2019
N/A
~40
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,559 Total Patients Enrolled
Hologic, Inc.Industry Sponsor
46 Previous Clinical Trials
60,029 Total Patients Enrolled
Carole KAMGA-NGANDE, MDPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My polyp is smaller than 2 cm.I have a narrowed cervical canal.My fibroids are 4 cm or smaller in total if I have more than one.I have a blood disorder.I have a small fibroid inside the wall of my uterus.I have a polyp or fibroid larger than 2 cm.
Research Study Groups:
This trial has the following groups:- Group 1: Standard hysteroscopy
- Group 2: Vaginoscopy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger